Direct Noise Reduction in the Intensive Care Units (ICU) Using Earplugs and Noise Canceling Headphones
Primary Purpose
Delirium, Sleep Fragmentation
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Foam Earplugs
Noise Canceling Headphones
Sponsored by
About this trial
This is an interventional prevention trial for Delirium focused on measuring ICU Delirium, Delirium, Sleep Quality, Sleep Efficiency, ICU Noise, Noise Reduction, Earplugs, Noise Canceling Headphones
Eligibility Criteria
Inclusion Criteria:
- Adult patients who are admitted to our MICU for at least 24 hours with at least 72 hours' additional expected stay in ICU, and who are mechanically ventilated
Exclusion Criteria:
- severe to profound hearing loss
- baseline use of hearing aids
- eardrum perforation
- severe cerumen impaction
- head or oromaxillofacial trauma
- external ventricular drain or intracranial pressure monitoring devices
- comatose patients who are deemed by their attending physician as unlikely to awaken within 72 hours
- patient status as comfort-measures only
- any other contraindication to the use of earplugs or headphones
Sites / Locations
- Wake Forest Baptist Medical Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
No Intervention
Active Comparator
Active Comparator
Arm Label
Usual Care
Earplugs
Earplugs and Headphones
Arm Description
Usual Care between 10pm-6am
Application of foam earplugs from 10pm-6am nightly for seven nights or until ICU discharge.
Foam Earplugs and Noise canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.
Outcomes
Primary Outcome Measures
Days Free of Delirium or Coma
Secondary Outcome Measures
Noise Attenuation
The reduction in noise experienced by the subject when using the study intervention.
Sleep Efficiency and Architecture
Staging of sleep with efficiency determined as a ratio of total sleep time/total study time.
Amount of Sedative Use (Midazolam and Lorazepam)
Amount of Analgesic Use
Mean of analgesic daily use
Amount of Sedative Use (Propofol and Demedetomidine )
Mean of sedative daily use (Propofol and Demedetomidine )
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01343095
Brief Title
Direct Noise Reduction in the Intensive Care Units (ICU) Using Earplugs and Noise Canceling Headphones
Official Title
A Randomized Controlled Trial of Direct Noise Reduction in the ICU Using Overnight Application of In-ear Earplugs or In-ear Earplugs Plus Noise-Canceling Headphones to Reduce the Incidence and Duration of ICU Delirium
Study Type
Interventional
2. Study Status
Record Verification Date
August 2018
Overall Recruitment Status
Terminated
Why Stopped
Loss of study staff
Study Start Date
May 2011 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
June 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wake Forest University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study seeks to examine the effects of overnight noise reduction in critically ill patients who are receiving mechanical ventilation. The investigators will randomly place subjects into one of three groups: 1) usual care 2) overnight earplugs 3) overnight earplugs and noise-canceling headphones. The investigators will monitor for safety, and will measure the amount of delirium experienced by subjects, record the amount of sedating and painkilling medicines required, and measure sleep quality during the study, among other information. The investigators will also measure noise levels experienced by patients in each group. The investigators predict that the use of overnight noise reduction will be safe and will reduce the amount of delirium by improving the quality of sleep in critically ill patients.
Detailed Description
Delirium is an acute confusional state defined by fluctuating mental status, inattention, and either disorganized thinking or an altered level of consciousness. Acute delirium is an increasingly recognized problem in intensive care units (ICUs) in the US and worldwide. ICU Delirium has been estimated to occur in as many as 50 to 80 percent of ICU patients. Delirium in the ICU has been associated with worsened clinical outcomes such as prolonged hospitalization and death [1-4]. Although noise has been shown to negatively influence sleep in the ICU, and sleep disturbance is a recognized contributor to ICU delirium[1-2, 4], there is no well-established link between ICU noise levels and the development of ICU delirium. Optimal strategies for the prevention and treatment of ICU delirium are yet to be defined, and this study will focus on a novel noise-reduction approach which has potential to impact both prevention and treatment [5-8]. Findings will be generalizable to other tertiary care medical intensive care units caring for adult patients.
Objectives Our multidisciplinary team will evaluate the safety and feasibility of direct noise reduction in the Wake Forest University Baptist Medical Center (WFUBMC) Medical Intensive Care Unit (MICU), and any effect on the incidence of ICU delirium.
Methods and Measures Design
Forty-five (45) patients receiving mechanical ventilation will be randomized to receive either passive direct noise reduction (earplugs), both passive and active direct noise reduction (earplugs and noise-canceling headphones), or no direct noise reduction (usual practice).
Ambient noise levels and the reduction in noise accomplished by direct noise reduction will be measured according to standardized audiometric techniques.
Sleep structure, including amount of recovery sleep, will be measured over one night according to standardized polysomnographic (sleep study) techniques
The incidence of delirium will be assessed as well as multiple other endpoints including but not limited to amount of psychoactive medication prescribed and amount of physical restraints required.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Delirium, Sleep Fragmentation
Keywords
ICU Delirium, Delirium, Sleep Quality, Sleep Efficiency, ICU Noise, Noise Reduction, Earplugs, Noise Canceling Headphones
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
8 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Usual Care between 10pm-6am
Arm Title
Earplugs
Arm Type
Active Comparator
Arm Description
Application of foam earplugs from 10pm-6am nightly for seven nights or until ICU discharge.
Arm Title
Earplugs and Headphones
Arm Type
Active Comparator
Arm Description
Foam Earplugs and Noise canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.
Intervention Type
Device
Intervention Name(s)
Foam Earplugs
Intervention Description
Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer)
Intervention Type
Device
Intervention Name(s)
Noise Canceling Headphones
Intervention Description
Noise Canceling headphones applied over the ears between 10pm-6am nightly. Model is Bose QuietComfort 15, manufactured by Bose Technologies.
Primary Outcome Measure Information:
Title
Days Free of Delirium or Coma
Time Frame
During the Study Period (Study Days 0-7 while patients were in ICU)
Secondary Outcome Measure Information:
Title
Noise Attenuation
Description
The reduction in noise experienced by the subject when using the study intervention.
Time Frame
Overnight (10pm-6am) on study day 2 or 3.
Title
Sleep Efficiency and Architecture
Description
Staging of sleep with efficiency determined as a ratio of total sleep time/total study time.
Time Frame
Overnight (10pm-6am) on study day 2 or 3
Title
Amount of Sedative Use (Midazolam and Lorazepam)
Time Frame
During the Study Period (Study Days 0-7)
Title
Amount of Analgesic Use
Description
Mean of analgesic daily use
Time Frame
During the Study Period (Study Days 0-7)
Title
Amount of Sedative Use (Propofol and Demedetomidine )
Description
Mean of sedative daily use (Propofol and Demedetomidine )
Time Frame
During the Study Period (Study Days 0-7)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult patients who are admitted to our MICU for at least 24 hours with at least 72 hours' additional expected stay in ICU, and who are mechanically ventilated
Exclusion Criteria:
severe to profound hearing loss
baseline use of hearing aids
eardrum perforation
severe cerumen impaction
head or oromaxillofacial trauma
external ventricular drain or intracranial pressure monitoring devices
comatose patients who are deemed by their attending physician as unlikely to awaken within 72 hours
patient status as comfort-measures only
any other contraindication to the use of earplugs or headphones
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Matthew C Miles, MD
Organizational Affiliation
Wake Forest University Health Sciences
Official's Role
Study Director
Facility Information:
Facility Name
Wake Forest Baptist Medical Center
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27157
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
de-identified data was shared with another investigator as part of a review and meta-analysis
Learn more about this trial
Direct Noise Reduction in the Intensive Care Units (ICU) Using Earplugs and Noise Canceling Headphones
We'll reach out to this number within 24 hrs